Diabetes - Type 1 Clinical Trials


Pancreas Volume in Preclinical Type 1 Diabetes

Type 1 diabetes (T1D) is characterized by a progressive destruction of insulin producing beta cells, resulting in a lifelong dependence on exogenous insulin. While beta cells make up less than 1% of the pancreas, studies have demonstrate...

Learn More

Bone and Vascular Health in Postmenopausal Women With Type 1 Diabetes

The study is aimed to evaluate the differences in bone mineral density (BMD) and Carotid Intima Media Thickness (CIMT) between postmenopausal women with type 1 diabetes (T1D) compared to postmenopausal women without diabetes.

Learn More

Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes

This purpose of this study is to determine if activation of a person's immune system in the small intestine could be a contributing cause of Type 1 Diabetes.

Learn More

Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.

Condition:   Type 1 Diabetes
Intervention:   Procedure: controlled physical activity
Sponsor:   University Hospital, Clermont-Ferrand
Not yet recruiting - verified May 2017

Learn More

Needs Assessment of Mediterranean Adolescents With Type 1 Diabetes About Therapeutic Education Sessions

Condition:   Type 1 Diabetes in Adolescence
Intervention:   Behavioral: education programs
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified July 2016

Learn More

Roles of T Helper 1 Cytokines in Type 1 Diabetes

Condition:   Type 1 Diabetes
Intervention:  
Sponsor:   Istanbul Medeniyet University
Completed - verified March 2015

Learn More

An Internet Cognitive-Behavioral Intervention for Youth With Type 1 Diabetes - Participation and Efficacy

Condition:   Type 1 Diabetes
Intervention:   Behavioral: An Internet Cognitive-Behavioral Intervention
Sponsors:   Dr. Orit Hamiel;   Academic College of Tel Aviv-Jaffa;   Maccabi Healthcare Services, Israel
Completed - verified February 2015

Learn More

The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes

Condition:   Type 1 Diabetes
Interventions:   Drug: Saxagliptin;   Drug: Insulin
Sponsor:   Nanjing Medical University
Recruiting - verified July 2016

Learn More

CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal Study

Condition:   Type 1 Diabetes
Intervention:  
Sponsors:   Liverpool John Moores University;   Royal Liverpool and Broadgreen University Hospitals NHS Trust
Completed - verified July 2015

Learn More

CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional Study

Condition:   Type 1 Diabetes
Intervention:  
Sponsors:   Liverpool John Moores University;   Royal Liverpool and Broadgreen University Hospitals NHS Trust
Completed - verified April 2015

Learn More

Pancreas Volume in Preclinical Type 1 Diabetes

Condition:   Type 1 Diabetes
Intervention:   Procedure: MRI, US, and blood samples
Sponsor:   University of Florida
Recruiting - verified April 2017

Learn More

Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes.

Condition:   Type 1 Diabetes Mellitus
Interventions:   Behavioral: Resistance exercise session;   Behavioral: Aerobic exercise session
Sponsor:   Hospital de Clinicas de Porto Alegre
Unknown status - verified July 2013

Learn More

Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia

Condition:   Type 1 Diabetes
Intervention:   Device: Predictive Low Glucose Minimizer
Sponsor:   Animas Corporation
Completed - verified September 2013

Learn More

Effects of Metreleptin in Type 1 Diabetes Mellitus

Condition:   Type 1 Diabetes
Intervention:   Drug: Leptin
Sponsors:   University of Texas Southwestern Medical Center;   Juvenile Diabetes Research Foundation;   Amylin Pharmaceuticals, LLC.
Terminated - verified May 2016

Learn More

Towards Simple and Non-invasive Assessment of Residual Beta-cell Function in Type 1 Diabetes

Condition:   Type 1 Diabetes
Intervention:   Other: Mixed meal stimulated urinary C peptide for the assessment of residual beta cell function
Sponsor:   University Hospitals Bristol NHS Foundation Trust
Completed - verified January 2016

Learn More

Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes

Condition:   Type 1 Diabetes
Interventions:   Drug: Sitagliptin;   Drug: Sugar Pill
Sponsor:   University of Colorado Denver School of Medicine Barbara Davis Center
Completed - verified May 2014

Learn More

Profiling of Original Cellular and Humoral Biomarkers of Type 1 Diabetes

Condition:   Type 1 Diabetes
Intervention:   Other: Blood samplings
Sponsor:   Nantes University Hospital
Completed - verified September 2015

Learn More

Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes

Condition:   Type 1 Diabetes Mellitis
Intervention:  
Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH)
Active, not recruiting - verified May 2017

Learn More

Beta Cell Function in (Pre) Type 1 Diabetes

Condition:   Type 1 Diabetes
Intervention:   Drug: glucose 20%
Sponsor:   AZ-VUB
Unknown status - verified December 2013

Learn More

Transdermal Basal Insulin Patch Study in Type 1 Diabetes

Condition:   Type 1 Diabetes
Intervention:   Other: PassPort(R) Transdermal Insulin Delivery System
Sponsor:   Altea Therapeutics
Completed - verified December 2010

Learn More

1-20 of 23
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.